Skip to content
★ Sign in to follow
JM

John Matthew Radak

Invitrogen CorpQuidel Corp
Total declarations
15
Companies
2
▲ Purchases (4 ops.)
€18k
▼ Sales (2 ops.)
€58k

Latest filing published 05 Jan 2011 for QUIDEL CORP.

Insider track record

Disclosed buys
4
Disclosed sells
2
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 14 Jun 2010 · 5992 days ago · €8,758
    +23.9%
    Entry 12.39 · Close at T+365 15.35

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

John Matthew Radak: trading record in brief

John Matthew Radak discloses dealings in 2 companies, chiefly Quidel Corp and Invitrogen Corp. Between 15 May 2006 and 3 January 2011, the trades on record add up to 15 filings.

Both buying and selling appear: 4 purchases worth €18k, against 2 sales worth €58k. Netting one side against the other leaves €40k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 6 share grants and 2 option exercises.

In size, the median ticket on the buying side is €3,651.

The newest entry dates from 5 January 2011: an option exercise, in Quidel Corp. The last purchase on record was published on 22 June 2010, which is 5,984 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to John Matthew Radak

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ◇
    Chief Financial OfficerExecutivesQuidel Corp
    0SEC
    153 sharesCommon StockSEC:0001209191-11-002128:0
  • ◆
    Chief Financial OfficerExecutivesQuidel Corp
    914 USD0SEC
    62 shares@ US$14.74Common StockSEC:0001209191-11-002128:1
  • ▲
    Chief Financial OfficerExecutivesQuidel Corp
    10,610 USD0SEC
    1,000 shares@ US$10.61Common StockSEC:0001209191-10-034132:0
    Canonical exit: 8 Sept 2010 (T+90)
  • ◆
    Chief Financial OfficerExecutivesQuidel Corp
    2,294 USD0SEC
    200 shares@ US$11.47Common StockSEC:0001209191-10-030249:0
  • ◆
    Chief Financial OfficerExecutivesQuidel Corp
    6,882 USD0SEC
    600 shares@ US$11.47Common StockSEC:0001209191-10-030249:2
  • ◆
    Chief Financial OfficerExecutivesQuidel Corp
    161 USD0SEC
    16,083 shares@ US$0.01Common StockSEC:0001209191-10-019890:0
  • ●
    Chief Financial OfficerExecutivesQuidel Corp
    81,464 USD0SEC
    5,745 shares@ US$14.18Common StockSEC:0001209191-10-019890:1
  • ◆
    Chief Financial OfficerExecutivesQuidel Corp
    95 USD0SEC
    9,498 shares@ US$0.01Common StockSEC:0001209191-10-004072:0
  • ◇
    VP Finance & AccountingExecutivesInvitrogen Corp
    22,602 USD0SEC
    761 shares@ US$29.70Common StockSEC:0001216855-07-000002:0
  • ▼
    VP Finance & AccountingExecutivesInvitrogen Corp
    48,917 USD0SEC
    761 shares@ US$64.28Common StockSEC:0001216855-07-000002:1
  • ▼
    VP Finance & AccountingExecutivesInvitrogen Corp
    26,418 USD0SEC
    394 shares@ US$67.05Common StockSEC:0001216855-06-000003:0

11 of 11 declarations